VAXCYTE INC's ticker is PCVX and the CUSIP is 92243G108. A total of 201 filers reported holding VAXCYTE INC in Q3 2023. The put-call ratio across all filers is 0.83 and the average weighting 0.5%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,364,633 | +4.7% | 26,768 | +2.6% | 0.00% | 0.0% |
| Q2 2023 | $1,303,334 | +101.5% | 26,098 | +51.2% | 0.00% | +50.0% |
| Q1 2023 | $646,830 | -21.8% | 17,258 | 0.0% | 0.00% | 0.0% |
| Q4 2022 | $827,521 | +165.2% | 17,258 | +32.7% | 0.00% | +100.0% |
| Q3 2022 | $312,000 | +10.2% | 13,008 | 0.0% | 0.00% | 0.0% |
| Q2 2022 | $283,000 | -9.6% | 13,008 | +0.2% | 0.00% | 0.0% |
| Q1 2022 | $313,000 | +1.3% | 12,978 | 0.0% | 0.00% | 0.0% |
| Q4 2021 | $309,000 | -5.2% | 12,978 | +1.1% | 0.00% | 0.0% |
| Q3 2021 | $326,000 | +14.0% | 12,841 | +1.2% | 0.00% | 0.0% |
| Q2 2021 | $286,000 | – | 12,691 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| Abingworth LLP | 4,168,718 | $82,124,000 | 28.36% |
| Medicxi Ventures Management (Jersey) Ltd | 1,887,478 | $37,277,000 | 21.71% |
| Pivotal bioVenture Partners Investment Advisor LLC | 1,405,421 | $27,757,000 | 8.90% |
| FRAZIER MANAGEMENT LLC | 2,309,554 | $45,614,000 | 3.66% |
| RA Capital Management | 3,865,808 | $76,350,000 | 1.15% |
| TPG Group Holdings (SBS) Advisors, Inc. | 4,558,475 | $90,030,000 | 1.05% |
| Soleus Capital Management, L.P. | 293,650 | $5,800,000 | 1.04% |
| Opaleye Management Inc. | 357,800 | $7,067,000 | 1.04% |
| SABBY MANAGEMENT, LLC | 178,992 | $3,535,000 | 0.69% |
| Penn Mutual Asset Management, LLC | 22,227 | $439,000 | 0.50% |